MONTREAL, May 07, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that has assumed full commercial activities and is relaunching ONICIT® IV (palonosetron) in Brazil and Mexico, through its affiliates in those countries (United …
VANCOUVER, BC, April 10, 2025 /CNW/ - Canfor Corporation (TSX: CFP) announced the company's upcoming webcast Annual General Meeting (the "Meeting") on May 8, 2025. The Company will hold a joint analyst conference call with Canfor Pulp Products Inc. (TSX: CFX) the following day …
VANCOUVER, BC, May 7, 2025 /CNW/ - Premium Brands Holdings Corporation (TSX: PBH), a leading producer, marketer and distributor of branded specialty food products, announced today its results for the first quarter of 2025. QUARTER HIGHLIGHTS Record first quarter revenue of $1.68 billion representing …
NEW BRIGHTON, Minn., May 07, 2025--(BUSINESS WIRE)--APi Group Corporation (NYSE: APG) ("APi" or the "Company") today announced it will webcast its 2025 Investor Day beginning at 9:00 a.m. ET on Wednesday, May 21, 2025. The event should conclude at approximately 12:00 p.m. ET. Presentations …
Analysis charts the emergence and future of advanced therapies DUBLIN, Ohio, May 7, 2025 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) released its 2025 Advanced Therapies Report: Revolutionizing patient care – the promise and potential of cell and gene therapies, providing insights into the …
- End-of-Phase 2 meeting with FDA requested for Alzheimer’s disease - - Phase 2 results in dementia with Lewy bodies accepted for oral presentation at AAIC - - Two posters at ARVO describezervimesine's role supporting retinal cell health - PURCHASE, N.Y., May 07, 2025 …
(Bloomberg) -- In this year’s hotly contested race for New Jersey governor, some Democratic hopefuls are embracing a strategy that helped propel Republican Donald Trump back to the White House: They support crypto, and they’re not afraid to say it. Most Read from Bloomberg …
Delivered year-over-year earnings and revenue growth; 2025 earnings outlook unchanged Net sales growth returned with Q1 EPS exceeding expectations as productivity gains continued GAAP EPS $0.29 (-22% YoY) / non-GAAP EPS $0.44 (+19% YoY) Q1 GAAP operating margin 4.1%; non-GAAP operating margin 5.3% reaches …
Announces successful completion of sub-chronic and chronic toxicology studies for INF904, supporting long-term dosing in future clinical trialsMultiple near-term catalysts anticipated with the potential to substantially de-risk the Company's pipeline addressing multiple sizable marketsInterim analysis for vilobelimab Phase 3 trial in pyoderma gangrenosum (PG), …
Broad-based increases in resilient and transactional revenues drove fourth consecutive quarter of double-digit revenue growth CHICAGO, May 7, 2025 /PRNewswire/ -- Jones Lang LaSalle Incorporated (NYSE: JLL) today reported operating performance for the first quarter of 2025 with diluted earnings per share of $1.14 …